It is currently unclear whether the addition of miniaturized dystrophin will mitigate disease progression as effectively as the somewhat larger proteins expressed in patients with Becker muscular dystrophy, particularly because some dystrophic changes will have occurred before gene therapy. The gene discussed is DMD; the disease is Becker muscular dystrophy.